BEVERLY HILLS, CA, October 28, 2010 (Press-News.org) Patients with severe acne scars often resort to multiple treatments, but seeing only minimal results, start to suffer from a low self-image. Coolaser Laser Resurfacing, a technique developed by Dr. Simon Ourian of Epione Medical Corporation in Beverly Hills, is a highly effective treatment used by many individuals to restore clear skin and eliminate unsightly acne scars.
Dr. Ourian's Coolaser technology is a highly individualized process, with a treatment regime customized for each patient. "Facial acne scars affect everybody differently," said Dr. Ourian, medical director at Epione Medical. "That's why over-the-counter treatments often don't measure up. A big part of our procedure is taking into account your own situation, and deciding what's best for you. I developed the Coolaser technique to achieve positive, long-lasting results, leaving you with clear, smooth skin."
Coolaser decreases the level of comfort patients experience by means of cooling the skin throughout the course of the treatment. Light pulses are projected onto the affected skin surface, and when the skin absorbs that light energy, the blemishes vaporize, one microscopic layer at a time. This approach allows the physician to retain precise control over treatment. The cooling makes the procedure much more comfortable than other types of laser treatments and microdermabrasion, and there is typically no long recovery period required.
When necessary, Dr. Ourian will augment the Coolaser treatment with dermal filler injections. Coolaser in effect "sands down" the surface of the skin and injectable products such as Radiesse, Juvederm and Restylane literally plump up the depressions in the skin caused by acne scars.
Dr. Ourian's Coolaser acne scar treatment has provided welcome relief to many patients, who not only appreciate the highly effective treatment, but also the excellent service and accommodating staff. "I love coming to Epione. I feel like I'm at a five star hotel! Everyone has a smile on their face and I love that," said one of Dr. Ourian's patients. Another related, "Since I don't live in L.A., I really appreciate Epione, and it's always a relief to leave L.A. looking younger."
Patients with all skin types and skin tones can benefit from the Coolaser treatment. Patients enjoy the spa-like atmosphere of the Epione Medical Center, and most patients report that the Coolaser procedure is relatively pain-free. The treatment is designed to be very precise, and targeted only at the affected areas--and the results are dramatic, with many patients reporting results beyond their expectations.
Dr. Ourian and the Epione laser and aesthetic medical center specialize in minimally invasive procedures. To learn more about Epione Beverly Hills and its signature products and treatments, visit www.epione.com. Sign up for Epione's newsletter and receive a $100 gift card instantly.
About Epione Medical Corporation
Epione, located in the heart of Beverly Hills, is one of the most comprehensive, state-of-the-art laser and aesthetic medical centers of its kind in the world. Epione is designed to offer clients comfort, convenience and privacy. The practice specializes in the most current technology available for skin, hair, and body contouring, and its staff is dedicated to providing clients with the highest level of personal attention and care. For more information, call Epione at (888) 951-3377 or visit www.epione.com.
Coolaser Laser Resurfacing from Dr. Simon Ourian Treats Acne Scars; Individualized Procedure Sets the Bar for Facial Acne Scar Treatments
Coolaser Laser Resurfacing, a technique developed by Dr. Simon Ourian of Epione Medical Corporation in Beverly Hills, is a highly effective treatment used by many individuals to restore clear skin and eliminate unsightly acne scars.
2010-10-28
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
HyProCure Stent to Fix Foot Pain Celebrates Six Years: Minimally Invasive Implant Continues to Reverse Devastating Foot Condition and Restore Patients' Quality of Life Worldwide
2010-10-28
Just a few short years ago, the HyProCure sinus tarsi stent, a small titanium implant no longer than a paper clip, was an inspiration on a sketch pad and a dream to help people live a life free of debilitating foot pain.
At that time, Dr. Michael E. Graham, the podiatric surgeon and creator of HyProCure, was searching for a better way to help his patients suffering from a very common and often devastating foot condition known as talotarsal dislocation syndrome (TTDS). TTDS is an abnormal motion of the ankle on the hindfoot bones causing the foot to become misaligned ...
Dr. Schellhammer has "Cracked the Mystery of Humanity"
2010-10-28
Despite the advances humankind has made in technology, science, communication and spirituality over the past thousand years, human beings have yet to solve the most important, intriguing mysteries of humanity.
What is the meaning of life? Is there a God? Why is there suffering and death? What happens when I die? Who am I? Every day across the globe, billions of people are asking these questions, left unsatisfied with the answers.
Dr. Edward Schellhammer's Individuation Academy aims to form life counselors and coaches for the Third Millennium. "We intend to provide ...
Alliance Benefit Group Receives Industry Award
2010-10-28
Alliance Benefit Group, LLC (ABG) received an Excellence in Communications award at the recent annual meeting for the Retirement Income Industry Association (RIIA). The RIIA annually selects what they deem as the communications materials, advertising and marketing initiatives that stand out across the retirement income industry.
ABG was named the winner of the Retail Retirement Income Communications Award sponsored by Investment News in the category of New Media. ABG earned the award for its submission of "Introducing a Smarter Way to Manage Your 401(k) Plan", a campaign ...
3D From Your Camera: Eos Systems Announces PhotoModeler 2010
2010-10-28
Eos Systems today announced the release of PhotoModeler 2010 and PhotoModeler Scanner 2010.
PhotoModeler, a Windows application, is used to create 3D models and measurements from photographs using ordinary digital cameras. PhotoModeler Scanner software adds the capability of creating dense point clouds like a laser or 3D scanner but eliminates the need for expensive and cumbersome equipment. The flexibility in using the ubiquitous digital camera offers sophisticated 3D capabilities for technical professionals and home users alike.
Both ends of this user spectrum ...
New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients
2010-10-27
(WASHINGTON, October 25, 2010) – An updated joint guideline by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) advises physicians about the appropriate use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat cancer patients with chemotherapy-induced anemia. While the guideline cautions that ESAs are associated with shorter survival and increased risk of thromboembolism — blood clots — and tumor progression, it also recognizes their major benefit ...
New class of biomolecules triggered in response to respiratory virus infection
2010-10-27
For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal's cells during a respiratory virus attack may affect the outcome of the infection. Their findings are reported today in mBio, a journal of the American Society for Microbiology.
RNA (ribonucleic acid) contains information transcribed from the cell's instruction manual, its DNA. The best known of these RNAs translate sections of DNA code into building blocks for proteins.
Most studies of how animals' cells respond to virus infection typically look at protein-coding ...
Landmark study finds high resting heart associated with shorter life expectancy
2010-10-27
Montreal −If you are a person who already has stable heart disease, how fast your heart beats at rest can predict your risk of dying, not only from heart disease but all other causes, Dr. Eva Lonn told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
"The higher the heart rate, the higher the risk of death from cardiovascular and all causes, even after adjusting for all risk factors that could confound our results," says Dr. Lonn, a cardiologist and professor at McMaster University. ...
Severe sepsis associated with development of cognitive and functional disability in older patients
2010-10-27
Older adults who survived severe sepsis were more likely to develop substantial cognitive impairment and functional disability, according to a study in the October 27 issue of JAMA.
Hundreds of thousands of patients endure severe sepsis each year in the United States, according to background information in the article. "Although severe sepsis is the most common non-cardiac cause of critical illness, the long-term impact of severe sepsis on cognitive and physical functioning is unknown," the authors write.
Theodore J. Iwashyna, M.D., Ph.D., of the University of Michigan ...
Patients who survive sepsis are more than 3 times as likely to have cognitive problems
2010-10-27
Ann Arbor, Mich. — Older adults who survive severe sepsis are at higher risk for long-term cognitive impairment and physical limitations than those hospitalized for other reasons, according to researchers from the University of Michigan Health System.
Research to be published Oct. 27 in the Journal of the American Medical Association showed that 60 percent of hospitalizations for severe sepsis were associated with worsened cognitive and physical function among surviving older adults. The odds of acquiring moderate to severe cognitive impairment were 3.3 times higher ...
Colorectal cancer patients with gene mutation show better response to cancer agent
2010-10-27
Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA.
"Recent retrospective correlative analyses of metastatic colorectal cancer trials indicate that patients with KRAS-mutated tumors ...
LAST 30 PRESS RELEASES:
Delta-8 THC use highest where marijuana is illegal, study finds
Study shows blood conservation technique reduces odds of transfusion by 27% during heart surgery
Mapping an entire subcontinent for sustainable development
Complete brain activity map revealed for the first time
Children with sickle cell disease face higher risk of dental issues, yet many don’t receive needed care
First brain-wide map of decision-making charted in mice
Mechanical forces drive evolutionary change
Safe, practical underground carbon storage could reduce warming by only 0.7°C – almost 10 times less than previously thought
Chinese scientists reveal hidden extinction crisis in native flora
Patient reports aren’t anecdotal—they’re valuable data
Mount Sinai study discovers potential link between stress and type 2 diabetes
Hurricane Sandy linked to lasting heart disease risk in elderly
Precision genetic target provides hope for Barth syndrome treatment
Colorless solar windows: Transforming architecture into clean power plants
SwRI-proposed mission could encounter and explore a future interstellar comet like 3I/ATLAS up close
Obtaining prefrontal cortex biopsies during deep brain stimulation adds no risk to procedure
New research finds 62% of AFib patients were unaware of the condition before diagnosis
69 schools awarded wellness grants to support healthier communities nationwide
Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET statement
Nonregistration, discontinuation, and nonpublication of randomized trials
Improving the reporting on health equity in observational research (STROBE-Equity)
Bacteria that ‘shine a light’ on microplastic pollution
SeoulTech develop hybrid polymer-CNT electrodes for safer brain-machine interfaces
From symptoms to biology: Neurodegeneration in paraventricular thalamus in bipolar disorder
From longevity to cancer: Understanding the dual nature of polyamines
Faraday Institution commits a further £9M to battery research to deliver commercial impact
Study: Evaluating chatbot accuracy in the fast-changing blood cancer field
A ‘wasteful’ plant process makes a key prenatal vitamin. Climate change may reduce it.
Targeted cell removal offers treatment hope
Here we glow: New organic liquid provides efficient phosphorescence
[Press-News.org] Coolaser Laser Resurfacing from Dr. Simon Ourian Treats Acne Scars; Individualized Procedure Sets the Bar for Facial Acne Scar TreatmentsCoolaser Laser Resurfacing, a technique developed by Dr. Simon Ourian of Epione Medical Corporation in Beverly Hills, is a highly effective treatment used by many individuals to restore clear skin and eliminate unsightly acne scars.